108
Views
0
CrossRef citations to date
0
Altmetric
Commentaries

Hepatitis B virus antibody status provides new insights in diffuse large B-Cell lymphoma

& ORCID Icon
Pages 1281-1283 | Received 02 Feb 2021, Accepted 06 Feb 2021, Published online: 02 Mar 2021

References

  • Siegel RL, Miller KD, Fuchs HE, et al. CA: a cancer journal for clinicians. CA A Cancer J Clin. 2021;71(1):7–33.
  • Bhargava A, Khan S, Panwar H, et al. Occult hepatitis B virus infection with low viremia induces DNA damage, apoptosis and oxidative stress in peripheral blood lymphocytes. Virus Res. 2010;153(1):143–150.
  • Ren W, Ye X, Su H, et al. Genetic landscape of hepatitis B virus-associated diffuse large B-cell lymphoma. Blood. 2018;131(24):2670–2681.
  • Deng L, Song Y, Young KH, et al. Hepatitis B virus-associated diffuse large B-cell lymphoma: unique clinical features, poor outcome, and hepatitis B surface antigen-driven origin. Oncotarget. 2015;6(28):25061–25073.
  • Zinzani PL. The many faces of marginal zone lymphoma. Hematology Am Soc Hematol Educ Program. 2012;2012:426–432.
  • Taborelli M, Polesel J, Montella M, et al. Hepatitis B and C viruses and risk of non-Hodgkin lymphoma: a case-control study in Italy. Infect Agent Cancer. 2016;11(27):1–6.
  • Wang Y, Wang H, Pan S, et al. Capable infection of hepatitis B virus in diffuse large B-cell lymphoma. J Cancer. 2018;9(9):1575–1581.
  • Wang F, Yuan S, Teng KY, et al. High hepatitis B virus infection in B-cell lymphoma tissue and its potential clinical relevance. Eur J Cancer Prev. 2012;21(3):261–267.
  • Li M, Shen Y, Chen Y, et al. Characterization of hepatitis B virus infection and viral DNA integration in non-Hodgkin lymphoma. Int J Cancer. 2020;147(8):2199–2209.
  • Hu S, Chen N, Lu K, et al. The prognostic roles of hepatitis B virus antibody in diffuse large b-cell lymphoma patients. Leukemia & Lymphoma. 2021;62(3):1–15.
  • Sera T, Hiasa Y, Michitaka K, et al. Anti-HBs-positive liver failure due to hepatitis B virus reactivation induced by rituximab. Intern Med. 2006;45(11):721–724.
  • Wang F, Xu RH, Luo HY, et al. Clinical and prognostic analysis of hepatitis B virus infection in diffuse large B-cell lymphoma. BMC Cancer. 2008;8(1):115.
  • Yan X, Zhou M, Lou Z, et al. Diffuse large B-cell lymphoma with concurrent hepatitis B virus infection in the MabThera era: unique clinical features and worse outcomes. J Cancer Res Ther. 2018;14(Supplement):S248–S253.
  • Liu Z, Li S, Liu Y, et al. PD1 is highly expressed in diffuse large B-cell lymphoma with hepatitis B virus infection. PLOS One. 2017;12(6):e0180390.
  • Liu Z, Li S, Guo W, et al. MYC gene rearrangements are closely associated with poor survival of diffuse large B cell lymphoma with hepatitis B virus infection. Biomed Res Int. 2017;2017:1967648.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.